|
1) Wang A, Athan E, Pappas PA, et al. Contem-porary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007; 297: 1354-61
|
|
|
|
2) Gonzalez-Lavin L, McGrath LB, Amini S, et al. Homograft valve preparation and predicting viability at implantation. J Card Surg. 1988; 3: 309-12
|
|
|
|
|
|
3) Gall KL, Smith SE, Willmette CA, et al. Allograft heart valve viability and valve-processing vari-ables. Ann Thorac Surg. 1998; 65: 1032-8
|
|
|
|
|
|
4) Clarke DR. Value, viability, and valves. J Thorac Cardiovasc Surg. 2002; 124: 1-6
|
|
|
|
|
|
5) Barili F, Dainese L, Cheema FH, et al. Rates of cycling cells in cryopreserved valvular homo-graft: a preliminary study. Artif Organs. 2007; 31: 152-4
|
|
|
|
|
|
6) Saito A, Kakimi K, Motomura N, et al. Restriction of Methicillin-resistant Staphylococcus aureus growth in allogeneic vascular grafts by indole-amine 2, 3-dioxygenase. J Immunol. 2006; 176: S97
|
|
|
|
|
|
7) Tabaku M, Jashari R, Carton HF, et al. Processing of cardiovascular allografts: effectiveness of European Homograft Bank (EHB) antimicrobial treatment (cool decontamination protocol with low concentration of antibiotics). Cell Tissue Bank. 2004; 5: 261-6
|
|
|
|
|
|
8) Jashari R, Van Hoeck B, Tabaku M, et al. Banking of the human heart valves and the arteries at the European homograft bank (EHB)--overview of a 14-year activity in this Interna-tional Association in Brussels. Cell Tissue Bank. 2004; 5: 239-51
|
|
|
|
|
|
9) Jashari R, Tabaku M, Van Hoeck B, et al. Decontamination of heart valve and arterial allografts in the European Homograft Bank (EHB): comparison of two different antibiotic cocktails in low temperature conditions. Cell Tissue Bank. 2007; 8: 247-55
|
|
|
|
|
|
10) Donaldson RM, Ross DM. Homograft aortic root replacement for complicated prosthetic valve endocarditis. Circulation. 1984; 70: I178-81
|
|
|
|
|
|
11) Wang A, Pappas P, Anstrom KJ, et al. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J. 2005; 150: 1086-91
|
|
|
|
|
|
12) Anguera I, Miro JM, San Roman JA, et al. Periannular complications in infective endo-carditis involving prosthetic aortic valves. Am J Cardiol. 2006; 98: 1261-8
|
|
|
|
|
|
13) Sabik JF, Lytle BW, Blackstone EH, et al. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg. 2002; 74: 650-9; discussion 9
|
|
|
|
|
|
14) Lopes S, Calvinho P, de Oliveira F, et al. Allograft aortic root replacement in complex prosthetic endocarditis. Eur J Cardiothorac Surg. 2007; 32: 126-30
|
|
|
|
|
|
15) Mestres CA, Castro MA, Bernabeu E, et al. Preoperative risk stratification in infective endo-carditis. Does the EuroSCORE model work？ Preliminary results. Eur J Cardiothorac Surg. 2007; 32: 281-5
|
|
|
|
|
|
16) Chiappini B, Absil B, Rubay J, et al. The Ross procedure: clinical and echocardiographic follow-up in 219 consecutive patients. Ann Thorac Surg. 2007; 83: 1285-9
|
|
|
|
|
|
17) Boethig D, Goerler H, Westhoff-Bleck M, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur J Cardiothorac Surg. 2007; 32: 133-42
|
|
|
|
|
|
18) Schmidtke C, Dahmen G, Graf B, et al. Pulmonary homograft muscle reduction to reduce the risk of homograft stenosis in the Ross procedure. J Thorac Cardiovasc Surg. 2007; 133: 190-5
|
|
|
|
|
|
19) Ghez O, Tsang VT, Frigiola A, et al. Right ventricular outflow tract reconstruction for pulmonary regurgitation after repair of tetralogy of Fallot. Preliminary results. Eur J Cardiothorac Surg. 2007; 31: 654-8
|
|
|
|
|
|
20) Salehi M, Sattarzadeh R, Soleimani AA, et al. The ross operation: clinical results and echo-cardiographic findings. Asian Cardiovasc Thorac Ann. 2007; 15: 30-4
|
|
|
|
|
|
21) Sierra J, Christenson JT, Lahlaidi NH, et al. Right ventricular outflow tract reconstruction: what conduit to use？ Homograft or Contegra？ Ann Thorac Surg. 2007; 84: 606-10; discussion 10-1
|
|
|
|
|
|
22) Mestres CA, Castella M, Moreno A, et al. Cryopreserved mitral homograft in the tricuspid position for infective endocarditis: a valve that can be repaired in the long-term (13 years). J Heart Valve Dis. 2006; 15: 389-91
|
|
|
|
|